Study of Efficacy and Safety of Ribociclib (LEE011) in Combination With Topotecan and Temozolomide (TOTEM) in Pediatric Patients With Relapsed or Refractory Neuroblastoma and Other Solid Tumors
Novartis
Novartis
Y-mAbs Therapeutics
Children's National Research Institute
National Institutes of Health Clinical Center (CC)
Masonic Cancer Center, University of Minnesota